ClinicalTrials.gg
CompletedNCT06737432Updated Nov 16, 2026

Respiratory Knowledge Portal Computer and Phone Application to Improve Quality of Mechanical Ventilation by Reducing the Number of Ventilator Associated Events, Injury Created by the Ventilator and Unsafe Setting of Alarms.

An interventional study of RKP Monitoring Software in Ventilation, ARDS and Respiratory Failure, sponsored by The University of Texas Medical Branch, Galveston. Completed at 1 site in United States. Open to participants aged Up to 100 Years. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by The University of Texas Medical Branch, Galveston · Not applicable, Interventional, and Health services research

How we know

Updated Nov 16, 2026Now CompletedStudy documents posted+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
875
Allocation
Non-randomized
Ages
Up to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 349 studies in Respiratory Insufficiency with a site in United States — 44 open to participants now, 60 under way, 1 of them phase 3. Respiratory Insufficiency · United States.

Enrollment
21st of 253
875 · median 42
Started
2024
with 19 others
No phase
159 of 349
30 open now
Registered
319th of 349
by date

Among the 349 studies in Respiratory Insufficiency with a site in United States, this one is the 21st largest by enrollment of the 253 interventional ones that give a count, is one of 20 that started in 2024, is one of 159 with no phase, and was the 319th registered.

Respiratory Insufficiency

1,371 studies on the registry are indexed under Respiratory Insufficiency; 266 are open to participants now.

Browse Respiratory Insufficiency studies →

Open to participants now

44 of the 349 studies in Respiratory Insufficiency with a site in United States are open now. Recruiting first, the newest first:

39 more — sign in →

All 44 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 180 Respiratory Insufficiency studies recruiting now, 135 (75%) set no upper age limit and 18 (10%) stop at 75 or younger; 21 take children under 18; 20 take healthy volunteers.

This study: Up to 100 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 349 studies in Respiratory Insufficiency with a site in United States, or all of them as a file.
02

Study summary

Ventilator associated events (VAE) is a quality metric defined by 48 hours of stability followed by 48 hours of escalation of ventilator settings within the ICU. VAE have been associated with poor outcomes and increases the cost of care, yet is not easy to avoid. Operationalizing all the standards of care known to improve outcomes of those requiring mechanical ventilation in the critical care environment requires a comprehensive approach. ICU teams are encouraged to follow best practice protocols to help liberate and prevent VAEs. Yet, compliance with protocols in most ICUs is suboptimal for multiple reasons. With the advent of computerized mechanical ventilators capable of streaming data from breath to breath and biomedical integration systems (BMDI) such as Capsule (UTMB's BMDI system), software systems have been developed to help identify variances in the standard of care. Automation in near real-time ventilator data feedback has been shown to reduce the incidences of VAEs.

This quality improvement project will leverage Vyaire's Respiratory Knowledge Portal (RKP) to collect and store meaningful data regarding ventilator-associated events (VAE), alarm policy compliance, ventilator weaning, and lung protective analytics.

Goals:

  1. To collect quality metrics utilizing RKP from patients requiring mechanical ventilation over a 3-4-month period for a retrospective baseline analysis.
  2. Provide the RKP tool to the ICU team to determine if the use of RKP's webportal and Messenger Zebra phone app improves quality of mechanical ventilation and outcomes.
  3. To determine a return on investment (ROI) for a software system like RKP.
03

Conditions studied

  • Ventilation
  • ARDS
  • Respiratory Failure
  • Mechanical Ventilation
  • Ventilator-induced Lung Injury (VILI)
  • Quality Improvement
  • Ventilator Associated Events

Keywords

  • Computer aided mechanical ventilation
  • Mechanical ventilation quality
  • Mechanical ventilation
  • Mechanical ventilation safety
  • Ventilator monitoring application
04

Who can participate

Ages eligible
Up to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Subjects requiring invasive mechanical ventilation.
  2. Subjects is in one of the monitored Galveston campus ICUs.
  3. Ages 0-100

Exclusion criteria

Exclusion Criteria:

  1. Is in an ICU not monitored by RKP.
  2. Adults on high frequency ventilation (pediatric patients are NOT excluded).
  3. Any patient requiring ECMO.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
875 participants (actual)

Study arms

  • No intervention
    Control

    We will monitor without clinician use of the software.

  • Active comparator
    Use of RKP

    Use of RKP alerts to the standard of care.

    Other: RKP Monitoring Software

Interventions

  • OtherRKP Monitoring Software

    Use of RKP alerting and monitoring software.

06

What researchers measure

Primary outcomes

  1. Number of participants with Ventilator-Associated Events

    Time frame: 3-4 months

Secondary outcomes

  1. Number of Ventilator Alarm Set Outside of Compliance

    Ventilator alarms set by the RT

    Time frame: 3-4 months

  2. Duration of Days on mechanical ventilation

    Does the weaning of mechanical ventilation improve through the measurements of spontaneous breathing trials.

    Time frame: 3-4 months

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2024 to primary completion in Oct 2026, 28 months.

Of 360 non-industry interventional studies with no phase under Respiratory Insufficiency, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's 28 months is above that.

Counting every sponsor, half of 376 studies reached it within 24 months; a quarter within 10 and three quarters within 46.

Completion moved once since we started tracking on Sep 25, 2026: Dec 2026 → Oct 2026, on Nov 16, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 11, 2024
First posted
Dec 17, 2024
StartActual
Jun 1, 2024
Primary completionActual
Oct 30, 2026
CompletionActual
Oct 30, 2026was Dec 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Nov 16, 2026
Study completion
Dec 2026→Oct 30, 2026 (actual)
Nov 16, 2026
Documents
Show all 1 update
  1. Nov 16, 2026
    Active, not recruiting→Completed
    Study completion Dec 2026→Oct 30, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06737432
Collaborators
Vyaire Medical, Zoll Medical Corporation
Responsible party
Sponsor
First posted
Dec 17, 2024
Start date
Jun 1, 2024
Primary completion
Oct 30, 2026
Completion
Oct 30, 2026
Last update
Nov 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion